{
  "episodeNumber": 39,
  "title": "UKW039 Corona: Impfstoffe",
  "generatedAt": "2026-01-05T15:18:03.007Z",
  "dataSource": "extended-topics",
  "radarChart": {
    "values": {
      "Health": 0.9334932402965548,
      "Politics": 0,
      "Military": 0,
      "Technology": 0.06650675970344527,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 0,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "durations": {
      "Health": 4281,
      "Politics": 0,
      "Military": 0,
      "Technology": 305,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 0,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "topicCounts": {
      "Health": 11,
      "Politics": 0,
      "Military": 0,
      "Technology": 2,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 0,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "totalDurationSec": 4586,
    "totalTopics": 13
  },
  "timeline": [
    {
      "subject": "Technology",
      "startSec": 79,
      "endSec": 189,
      "durationSec": 110,
      "topic": "Lars Fischer",
      "fineSubject": "Virology",
      "topicIndex": 0
    },
    {
      "subject": "Technology",
      "startSec": 189,
      "endSec": 384,
      "durationSec": 195,
      "topic": "Faszination für Viren und Seuchen",
      "fineSubject": "Epidemiology",
      "topicIndex": 1
    },
    {
      "subject": "Health",
      "startSec": 384,
      "endSec": 1183,
      "durationSec": 799,
      "topic": "Stand der Dinge bei SARS-Cov-2",
      "fineSubject": "Infectious Diseases",
      "topicIndex": 2
    },
    {
      "subject": "Health",
      "startSec": 1184,
      "endSec": 1299,
      "durationSec": 115,
      "topic": "Der PCR-Test",
      "fineSubject": "Diagnostics",
      "topicIndex": 3
    },
    {
      "subject": "Health",
      "startSec": 1299,
      "endSec": 2053,
      "durationSec": 754,
      "topic": "Inaktivierte Viren",
      "fineSubject": "Vaccines",
      "topicIndex": 4
    },
    {
      "subject": "Health",
      "startSec": 2053,
      "endSec": 2678,
      "durationSec": 625,
      "topic": "DNA/RNA und Vektorimpfstoffe",
      "fineSubject": "Vaccines",
      "topicIndex": 5
    },
    {
      "subject": "Health",
      "startSec": 2679,
      "endSec": 2816,
      "durationSec": 137,
      "topic": "Lebendimpfstoffe",
      "fineSubject": "Vaccines",
      "topicIndex": 6
    },
    {
      "subject": "Health",
      "startSec": 2817,
      "endSec": 2960,
      "durationSec": 143,
      "topic": "Virusähnliche Partikel",
      "fineSubject": "Vaccines",
      "topicIndex": 7
    },
    {
      "subject": "Health",
      "startSec": 2960,
      "endSec": 3416,
      "durationSec": 456,
      "topic": "Welche Impfstoffe können helfen?",
      "fineSubject": "Vaccines",
      "topicIndex": 8
    },
    {
      "subject": "Health",
      "startSec": 3417,
      "endSec": 3584,
      "durationSec": 167,
      "topic": "Mögliche negative Auswirkungen",
      "fineSubject": "Vaccines",
      "topicIndex": 9
    },
    {
      "subject": "Health",
      "startSec": 3584,
      "endSec": 3904,
      "durationSec": 320,
      "topic": "Impfstoffentwicklung in Deutschland",
      "fineSubject": "Pharmaceuticals",
      "topicIndex": 10
    },
    {
      "subject": "Health",
      "startSec": 3904,
      "endSec": 4283,
      "durationSec": 379,
      "topic": "Ausblick",
      "fineSubject": "Public Health",
      "topicIndex": 11
    },
    {
      "subject": "Health",
      "startSec": 4284,
      "endSec": 4670,
      "durationSec": 386,
      "topic": "Mutation und Behandlungsoptionen",
      "fineSubject": "Infectious Diseases",
      "topicIndex": 12
    }
  ]
}
